GlassScriptPhysician profile
Kristin Nelson
NPI 1447874060
$2,748.53
in general payments reported to CMS, 2019-2025
14 companies · $966 in 2025
The $966 reported for 2025 was more than what 90% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $195 · 2023: $1,289 · 2024: $299 · 2025: $966.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,632 · Travel and Lodging: $922.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,631.94 |
| Travel and Lodging | $921.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $1,427.57 | 2022-2025 | Acuvue |
| Coopervision INC. | $278.51 | 2024-2025 | Misight Contact Lens, Myday Contact Lens |
| Biotissue Holdings INC. | $147.19 | 2025 | |
| Alcon Vision LLC | $136.93 | 2023-2025 | Tryptyr, Total30 |
| Dompe US, INC. | $124.96 | 2024 | Oxervate |
| Glaukos Corporation | $124.46 | 2025 | Idosetr |
| Bausch & Lomb Americas INC. | $120.36 | 2025 | Infuse |
| Tarsus Pharmaceuticals, INC. | $99.93 | 2025 | Xdemvy |
| Rxsight INC | $93.75 | 2022 | |
| Lkc Technologies, INC. | $88.46 | 2025 | |
| Oyster Point Pharma, INC. | $40.27 | 2022-2023 | Tyrvaya |
| Sun Pharmaceutical Industries INC. | $31.15 | 2022 | |
| Abbvie INC. | $19.04 | 2022 | |
| Novartis Pharmaceuticals Corporation | $15.95 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kristin Nelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.